… spread of coronavirus SARS-CoV-2 causing COVID-19 across … , the high mortality rate in
COVID-19 patients without visible … lungs, may be the result of at least three possible sources: …

… Although PPZ is popularly known as an antipsychotic drug, currently, it is also being
investigated for possible antiviral effect against COVID-19. PPZ is one of the compounds predicted …

… The merit of the “Early Treatment of Covid-19” with the “Covid … is to tackle Covid-19 in the
most effective way possible. Not … The “Early Treatment of Covid-19” with the “Covid Kit” drugs …

… in COVID-19. The present perspective places a central cellular pro-inflammatory signal pathway,
NF-κB, in the context of recently published data for COVID-19 … stage COVID-19 patients. …

… The authors also did not explain how the 15% of patients who received radiation therapy
were selected for this treatment. Therefore, it is possible that the trend to shorter illness in the …

… pathways and treatments in COVID-19-related anosmia and/or ageusia. According to available
data, there are limited studies about possible treatments of COVID-19 taste and smell loss…

… The medical community is currently facing a lack of efficacious treatment options for
COVID-induced … We believe that anti-inflammatory treatment for 6 months after COVID-associated …

… treatment response of TCZ therapy in COVID-19 infected patients. The demographic, treatment,
… It is the other possible risk factors, not an inflammatory activity, which may attribute to the …

… that, during the coronavirus disease 2019 (COVID-19) epidemic, … mechanism and treatment
strategies of the COVID-19 virus-… background to inform future guidance for clinical treatment. …

… the treatment of Covid-19. In this commentary, we have portrayed the structure of the coronavirus
in … The covid-19 pandemic might wean down by the end of summer 2020, but the risk of …